Experience
Orion Corp.
Wockhardt USA, Inc.
Represented Orion Corporation in multiple ANDA actions in D.N.J. and D. Del. related to Orion's Stalevo® and Comtan® products for the treatment of Parkinson’s disease.
Orion Corp. v. Wockhardt USA, Inc., 1:07-cv-00550; 1:08-cv-00917 , D. Del., Judges Sleet, Stark
Orion Corp. v. Sun Pharmaceutical Industries, Ltd., 1:07-cv-05436, 1:08-cv-00720, 1:08-cv-05545, D.N.J., Judges Cooper, Arpert, Hughes
Power Integrations, Inc. v. BCD Semiconductor Corp.
BCD Semiconductor Corp.
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
LG Electronics
Courtesy Products v. Royal Cup
Courtesy Products, LLC
Genetics Institute v. Novartis Vaccines and Diagnostics
Genetics Institute
UTStarcom, Inc. v. Starent Networks Corp.
Starent Networks Corp.
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.